CRISPR and Hepatitis E: A New Frontier in RNA-Targeting Antiviral Therapy
CRISPR technology provides a new hepatitis E treatment by targeting viral RNA, showing promise in human cells.
Category
Medical Research features evidence-based coverage of scientific studies, clinical trials, biomedical discoveries, translational research, and healthcare innovations that advance medical knowledge, improve patient outcomes, and support evidence-based clinical practice.
CRISPR technology provides a new hepatitis E treatment by targeting viral RNA, showing promise in human cells.